Solid tumour models for the assessment of different treatment modalities: IV. the combined effects of radiation and 5-fluorouracil
- PMID: 184808
- PMCID: PMC2025176
- DOI: 10.1038/bjc.1976.160
Solid tumour models for the assessment of different treatment modalities: IV. the combined effects of radiation and 5-fluorouracil
Abstract
Neither radiation alone (375 to 1500 rad) nor5-fluorouracil (FU) alone (50-250 mg/kg) is sufficient to prevent an increase in the volume of the solid tumour model hepatoma 3924A. However, as little as 750 rad with 100 mg/kg FU can reduce the tumour below the volume at the time of treatment for as long as 14 days. A series of combined FU and radiation doses given every 11 days should then result in successively smaller tumour volumes until the tumour is eradicated. Changes in tumour volume were analysed by two different methods: (1) tumours in each treatment mode were grouped together and the average response to treatment determined, and (2) tumour volume changes in individual tumours were analyzed utilizing the chi2 technique, which fits the logarithmic tumour volume change with time to polynomials. This two-directional method of analysis has the advantage of permitting both an overview of the main effects of treatment via the averages, and at the same time a detailed examination of the mechanism by which these effects occur through the analysis of individual response. The results suggest that, in addition to concentrating on the cellular response immediately after therapy, greater emphasis should be placed on the kinetic changes of the tumour 1-3 weeks after single or multiple modality therapy. These findings demonstrate how the sequencing of single and/or combined treatment modalities may be investigated in order to detemine how best to obtain maximum effects of treatment on different types of tumours following recovery of the host from the previous treatment series.
Similar articles
-
Solid tumour models for the assessment of different treatment modalities: VII: single vs fractionated doses of 5-fluorouracil on two solid tumours and their hosts.Br J Cancer. 1978 May;37(5):841-8. doi: 10.1038/bjc.1978.123. Br J Cancer. 1978. PMID: 207298 Free PMC article.
-
Solid tumor models for the assessment of different treatment modalities: systematics of response to radiotherapy and chemotherapy.Proc Natl Acad Sci U S A. 1976 Mar;73(3):818-22. doi: 10.1073/pnas.73.3.818. Proc Natl Acad Sci U S A. 1976. PMID: 176656 Free PMC article.
-
Solid tumor models for the assessment of different treatment modalities: VI: Perturbations in the kinetics of tumor and host organ cellular regulation demonstrated by single and combined experimental therapy.Adv Exp Med Biol. 1977 May 22-24;92:677-757. doi: 10.1007/978-1-4615-8852-8_27. Adv Exp Med Biol. 1977. PMID: 205112 No abstract available.
-
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5842-52. Clin Cancer Res. 2003. PMID: 14676105 Review.
-
Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.Q J Nucl Med Mol Imaging. 2011 Apr;55(2):168-97. Q J Nucl Med Mol Imaging. 2011. PMID: 21386789 Review.
Cited by
-
Solid tumor models for assessment of different treatment modalities: therapeutic strategy for sequential chemotherapy with radiotherapy.Proc Natl Acad Sci U S A. 1977 May;74(5):1983-7. doi: 10.1073/pnas.74.5.1983. Proc Natl Acad Sci U S A. 1977. PMID: 194245 Free PMC article.
-
Solid tumour models for the assessment of different treatment modalities: VII: single vs fractionated doses of 5-fluorouracil on two solid tumours and their hosts.Br J Cancer. 1978 May;37(5):841-8. doi: 10.1038/bjc.1978.123. Br J Cancer. 1978. PMID: 207298 Free PMC article.
-
Toxicity of 5-fluorouracil for aerobic and hypoxic cells in two murine tumours.Cancer Chemother Pharmacol. 1987;19(1):53-6. doi: 10.1007/BF00296256. Cancer Chemother Pharmacol. 1987. PMID: 3815727
-
Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate.Cancer Chemother Pharmacol. 1982;9(1):17-21. doi: 10.1007/BF00296755. Cancer Chemother Pharmacol. 1982. PMID: 7139849
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources